Alumis Inc. – Filings and Transcripts

NASDAQ: ALMS
Share price (7/21/26): $30.05
Market cap (7/21/26): $3.831 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Automatic shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Shelf registration

Ownership Filter

Tetrault Lynn A.

Srivastava Sapna

News Filter

Shareholder Vote Results

Investor Presentation

Reports First Quarter 2026 Financial Results and Highlights Recent Achievements

Alumis’ Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis

Reports Year End 2025 Financial Results and Highlights Recent Achievements

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission